Recover password
Please enter your email to reset your password.
This website is intended for GB healthcare professionals and other relevant decision makers
Members of the public
Unlock access to the Novo Nordisk Portal
Log in
Please enter your details.
Enter email*
This field is required
Enter password*
This field is required
Haven't registered yet?
UK24NNG00174 | October 2024
Missing validation
Before you can log in you need to validate your account by clicking the link in the email we have sent you.
A validation mail has been sent to you
Please check your email and click to link to validate your account.
hcpportalplus - Not validated
hcpportalplus - Not validated description
hcpportalplus - Not validated social
hcpportalplus - Not validated description social
Enter email*
This field is required
UK24NNG00174 | October 2024
You’re almost done
We have sent the password reset instructions to the email associated with this account.
UK24NNG00174 | October 2024
Reset your password
Enter password*
Between 8 - 64 characters
Uppercase, lowercase letter, number and special character
Password confirmation
UK24NNG00174 | October 2024
Your password has been changed
Log in to start exploring the portal.
UK24NNG00174 | October 2024
Create an account
This website is intended for GB healthcare professionals and other relevant decision makers
Enter your details
First name*
Last name*
Work email address*
Password*
Between 8 -64 characters
Uppercase, lowercase letter, number and special character
Must not contain your name or e-mail
Repeat password*
Interest
Which disease areas are you most interested in?
Diabetes
Obesity
Haemophilia
Growth disorders
Already have an account? Log in
UK24NNG00174 | October 2024
A user already exists with that email
The entered email is already in use.
Registration unsuccessful
Unfortunately your registration has not been successful. Please check your details have been entered correctly and try again.
Stay informed
Subscribe to receive updates from Novo Nordisk UK including education, events and product information (may contain promotional material) Enter your details
Create account
You are only one password away of creating an account and unlocking access to the entire Novo Nordisk Portal.
Success!
First name*
Last name*
Work email address*
Interest
Which disease areas are you most interested in?
Which disease areas are you most interested in?
Diabetes
Obesity
Haemophilia
Growth disorders
UK24NNG00174 | October 2024
A user already exists with that email
The entered email is already in use.
Registration unsuccessful
Unfortunately your registration has not been successful. Please check your details have been entered correctly and try again.
Interest
Which disease areas are you most interested in?
Which disease areas are you most interested in?
Diabetes
Obesity
Haemophilia
Growth disorders
UK24NNG00174 | October 2024
Driving change
Before we continue
This website has been developed by Novo Nordisk for GB (England, Scotland, Wales) healthcare professionals and other relevant decision makers* and contains promotional material on Novo Nordisk products as well as disease area information, education, and resources.
*Other relevant decision makers (ORDMs) particularly include those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not healthcare professionals.
If you are a member of the public, please click here
If you are a patient prescribed a Novo Nordisk product, please click here
Reporting of side effects
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes.
Adverse events
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes.